Login / Signup

Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.

Abbas TaherMarjan LashkariFariba KeramatSeyyed Hamid HashemiLadan SedighiJalal PoorolajalMaryam Mehrpooya
Published in: Wiener medizinische Wochenschrift (1946) (2023)
Based on the results, severe cases of COVID-19 treated with dexamethasone might have a better clinical status at 28-day follow-up compared to methylprednisolone and hydrocortisone at an equivalent dose. Larger multicenter trials are required to confirm our findings.
Keyphrases